162 related articles for article (PubMed ID: 14734460)
1. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.
Han W; Kang D; Park IA; Kim SW; Bae JY; Chung KW; Noh DY
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):124-30. PubMed ID: 14734460
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
3. Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women.
Yadav S; Singhal NK; Singh V; Rastogi N; Srivastava PK; Singh MP
Dis Markers; 2009; 27(5):203-10. PubMed ID: 20037207
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
6. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
7. Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients.
Ociepa-Zawal M; Rubiś B; Filas V; Breborowicz J; Trzeciak WH
Ginekol Pol; 2009 Nov; 80(11):819-23. PubMed ID: 20088394
[TBL] [Abstract][Full Text] [Related]
8. GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients.
Giess M; Lattrich C; Springwald A; Goerse R; Ortmann O; Treeck O
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):7-12. PubMed ID: 19744559
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.
Sillanpää P; Heikinheimo L; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Metsola K; Hirvonen A
Breast Cancer Res Treat; 2007 Sep; 104(3):287-97. PubMed ID: 17063266
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.
Kiruthiga PV; Kannan MR; Saraswathi C; Pandian SK; Devi KP
Asian Pac J Cancer Prev; 2011; 12(8):2133-8. PubMed ID: 22292665
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
[TBL] [Abstract][Full Text] [Related]
13. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
[TBL] [Abstract][Full Text] [Related]
14. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
15. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility.
Sharma KL; Agarwal A; Misra S; Kumar A; Kumar V; Mittal B
Tumour Biol; 2014 Jun; 35(6):5431-9. PubMed ID: 24535777
[TBL] [Abstract][Full Text] [Related]
19. Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Eur J Cancer Prev; 2004 Feb; 13(1):83-6. PubMed ID: 15075793
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
